| Ranked All-Publication list | Historiographs | Glossary HistCite Guide About |
| Nodes: 6555, Authors: 15733, Journals: 1105, Cited References: 140610, Words: 8620, Tags: 1
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
| View: Overview | Sorted by journal name. |
Page 11 of 66: 1 [ 11 12 13 14 15 16 17 18 19 20 ] 21 31 41 51 61
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
|---|---|---|---|---|---|
| 1001 | 14 | 33 | 2951 1999 CANCER 85 (3): 741-749 Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; et al. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors | 12 | 29 |
| 1002 | 15 | 30 | 2952 1999 CANCER 85 (4): 919-924 Rahat MA; Lahat N; Gazawi H; Resnick MB; Sova Y; et al. Telomerase activity in patients with transitional cell carcinoma - A preliminary study | 10 | 36 |
| 1003 | 25 | 38 | 2953 1999 CANCER 86 (4): 559-565 Jong HS; Park YI; Kim S; Sohn JH; Kang SH; et al. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis | 11 | 37 |
| 1004 | 20 | 29 | 2954 1999 CANCER 86 (6): 1056-1063 Wu KD; Lund M; Bang K; Thestrup-Pedersen K Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma | 7 | 17 |
| 1005 | 22 | 35 | 2955 1999 CANCER 86 (8): 1431-1436 Takagi S; Kinouchi Y; Hiwatashi N; Chida M; Nagashima F; et al. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas | 14 | 23 |
| 1006 | 15 | 17 | 2956 1999 CANCER 86 (10): 2038-2044 Wu A; Ichihashi M; Ueda M Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors | 21 | 47 |
| 1007 | 24 | 41 | 2957 1999 CANCER 86 (10): 2109-2116 Nakanishi K; Kawai T; Hiroi S; Kumaki F; Torikata C; et al. Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract | 7 | 11 |
| 1008 | 9 | 18 | 3363 2000 CANCER 88 (2): 312-317 Takaishi H; Kitamoto M; Takahashi S; Aikata H; Kawakami Y; et al. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay | 2 | 10 |
| 1009 | 8 | 44 | 3364 2000 CANCER 88 (2): 440-453 Sawyer JR; Husain M; Pravdenkova S; Krisht A; Al-Mefty O A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients | 3 | 21 |
| 1010 | 10 | 27 | 3365 2000 CANCER 88 (7): 1524-1529 Koyanagi K; Ozawa S; Ando N; Mukai M; Kitagawa Y; et al. Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus | 3 | 16 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 1011 | 24 | 39 | 3366 2000 CANCER 89 (2): 445-452 Ely SA; Chadburn A; Dayton CM; Cesarman E; Knowles DM Telomerase activity in B-cell non-Hodgkin lymphoma | 7 | 15 |
| 1012 | 28 | 41 | 3367 2000 CANCER 89 (10): 2092-2098 Chen HJ; Liang CL; Lu K; Lin JW; Cho CL Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas | 8 | 13 |
| 1013 | 37 | 59 | 3789 2001 CANCER 91 (3): 496-504 Sato N; Maehara N; Mizumoto K; Nagai E; Yasoshima T; et al. Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion | 3 | 10 |
| 1014 | 20 | 26 | 3790 2001 CANCER 92 (7): 1943-1948 Liu BCS; LaRose I; Weinstein LJ; Ahn M; Weinstein MH; et al. Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection | 3 | 12 |
| 1015 | 25 | 33 | 4227 2002 CANCER 95 (5): 1127-1133 Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; et al. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors | 6 | 16 |
| 1016 | 24 | 30 | 4228 2002 CANCER 95 (9): 1834-1839 Kawanishi-Tabata R; Lopez F; Fratantonio S; Kim N; Goldblum J; et al. Telomerase activity in stage II colorectal carcinoma - Telomerase-negative tumors are correlated with poor prognosis | 3 | 6 |
| 1017 | 26 | 47 | 4229 2002 CANCER 95 (10): 2103-2111 Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; et al. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma | 7 | 13 |
| 1018 | 31 | 40 | 4726 2003 CANCER 98 (1): 110-118 Yokota T; Suda T; Igarashi M; Kuroiwa T; Waguri N; et al. Telomere length variation and maintenance in hepatocarcinogenesis | 3 | 7 |
| 1019 | 13 | 100 | 1615 1995 CANCER AND METASTASIS REVIEWS 14 (1): 49-58 MORGAN WF; MURNANE JP A ROLE FOR GENOMIC INSTABILITY IN CELLULAR RADIORESISTANCE | 4 | 36 |
| 1020 | 22 | 44 | 4230 2002 CANCER BIOLOGY & THERAPY 1 (4): 391-397 Elmore LW; Turner KC; Gollahon LS; Landon MR; Jackson-Cook CK; et al. Telomerase protects cancer-prone human cells from chromosomal instability and spontaneous immortalization | 6 | 9 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 1021 | 10 | 21 | 4231 2002 CANCER BIOLOGY & THERAPY 1 (4): 398-400 Hahn WC Senescence, telomere shortening and telomere maintenance | 1 | 2 |
| 1022 | 19 | 50 | 4232 2002 CANCER BIOLOGY & THERAPY 1 (5): 511-517 Sood AK; Coffin J; Jabbari S; Buller RE; Hendrix MJC; et al. p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma | 3 | 8 |
| 1023 | 33 | 72 | 4727 2003 CANCER BIOLOGY & THERAPY 2 (2): 131-136 Nguyen B; Elmore LW; Holt SE Telomerase as a target for cancer immunotherapy | 0 | 3 |
| 1024 | 33 | 77 | 4728 2003 CANCER BIOLOGY & THERAPY 2 (4): S64-S70 Gu R; Fang BL Telomerase promoter-driven cancer gene therapy | 0 | 0 |
| 1025 | 19 | 27 | 5228 2004 CANCER BIOLOGY & THERAPY 3 (3): 289-292 de Caceres II; Frolova N; Varkonyi RJ; Dulaimi NJ; Broccoli D; et al. Telomerase is frequently activated in tumors with microsatellite instability | 0 | 1 |
| 1026 | 19 | 40 | 5768 2005 CANCER BIOLOGY & THERAPY 4 (10): 1098-1103 Hao ZM; Luo JY; Cheng J; Li L; He DL; et al. Intensive inhibition of hTERT expression by a ribozyme induces rapid apoptosis of cancer cells through a telomere length independent pathway | 1 | 1 |
| 1027 | 70 | 103 | 4233 2002 CANCER CELL 2 (4): 257-265 Shay JW; Wright WE Telomerase: A target for cancer therapeutics | 48 | 82 |
| 1028 | 25 | 70 | 4234 2002 CANCER CELL 2 (5): 401-413 Seger YR; Garcia-Cao M; Piccinin S; Cunsolo CL; Doglioni C; et al. Transformation of normal human cells in the absence of telomerase activation | 21 | 63 |
| 1029 | 5 | 41 | 5229 2004 CANCER CELL 5 (3): 263-273 Crawford YG; Gauthier ML; Joubel A; Mantei K; Kozakiewicz K; et al. Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program | 0 | 25 |
| 1030 | 27 | 90 | 5230 2004 CANCER CELL 6 (3): 215-222 Hahn WC Cancer: Surviving on the edge | 2 | 6 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 1031 | 34 | 54 | 5231 2004 CANCER CELL 6 (4): 373-385 Argilla D; Chin K; Singh M; Hodgson JG; Bosenberg M; et al. Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes | 3 | 5 |
| 1032 | 33 | 50 | 5769 2005 CANCER CELL 7 (1): 25-37 Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics | 7 | 17 |
| 1033 | 29 | 177 | 2524 1998 CANCER CHEMOTHERAPY AND PHARMACOLOGY 42: S3-S21 Boral AL; Dessain S; Chabner BA Clinical evaluation of biologically targeted drugs: Obstacles and opportunities | 5 | 23 |
| 1034 | 21 | 51 | 5232 2004 CANCER CHEMOTHERAPY AND PHARMACOLOGY 54 (2): 161-172 Bakalova R; Ohba H; Zhelev Z; Kubo T; Fujii M; et al. Atypical protein-kinase C zeta, but neither conventional Ca2+-dependent protein-kinase C isoenzymes nor Ca2+-calmodulin, participates in regulation of telomerase activity in Burkitt's lymphoma cells | 0 | 0 |
| 1035 | 14 | 37 | 5770 2005 CANCER CHEMOTHERAPY AND PHARMACOLOGY 56 (1): 22-28 Murakami J; Asaumi J; Kawai N; Tsujigiwa H; Yanagi Y; et al. Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer | 0 | 0 |
| 1036 | 5 | 25 | 6287 2006 CANCER CHEMOTHERAPY AND PHARMACOLOGY 57 (3): 328-334 Zou L; Zhang PH; Luo CL; Tu ZG shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity | 0 | 0 |
| 1037 | 11 | 38 | 6288 2006 CANCER CHEMOTHERAPY AND PHARMACOLOGY 58 (4): 434-443 Yu J; Guo QL; You QD; Lin SS; Li Z; et al. Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells | 0 | 0 |
| 1038 | 26 | 33 | 2958 1999 CANCER CYTOPATHOLOGY 87 (2): 93-99 Mu XC; Brien TP; Ross JS; Lowry CV; McKenna BJ Telomerase activity in benign and malignant cytologic fluids | 2 | 14 |
| 1039 | 17 | 23 | 2959 1999 CANCER CYTOPATHOLOGY 87 (4): 210-215 Naritoku WY; Datar RH; Li PL; Groshen SL; Taylor CR; et al. Telomerase activity - Comparison between fine-needle aspiration and biopsy specimens for the detection of tumor cells | 1 | 5 |
| 1040 | 16 | 37 | 2162 1997 CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 6 (6): 413-420 Kannan S; Tahara H; Yokozaki H; Mathew B; Nalinakumari KR; et al. Telomerase activity in premalignant and malignant lesions of human oral mucosal | 26 | 37 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 1041 | 2 | 15 | 5771 2005 CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 14 (11): 2772S-2773S Dhabhar FS Enhancing versus suppressive effects of stress on immune function: Basic mechanisms and clinical implications. | 0 | 0 |
| 1042 | 15 | 25 | 6289 2006 CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 15 (3): 573-577 O'Sullivan J; Risques RA; Mandelson MT; Chen L; Brentnall TA; et al. Telomere length in the colon declines with age: a relation to colorectal cancer? | 0 | 0 |
| 1043 | 14 | 53 | 6290 2006 CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 15 (8): 1451-1457 Finley JC; Reid BJ; Odze RD; Sanchez CA; Galipeau P; et al. Chromosomal instability in Barrett's esophagus is related to telomere shortening | 0 | 0 |
| 1044 | 14 | 25 | 3791 2001 CANCER GENE THERAPY 8 (10): 827-834 Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells | 38 | 44 |
| 1045 | 22 | 31 | 4235 2002 CANCER GENE THERAPY 9 (7): 624-630 Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; et al. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells | 10 | 16 |
| 1046 | 13 | 55 | 4729 2003 CANCER GENE THERAPY 10 (3): 239-249 Frolkis M; Fischer MB; Wang Z; Lebkowski JS; Chiu CP; et al. Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors | 4 | 13 |
| 1047 | 8 | 32 | 5233 2004 CANCER GENE THERAPY 11 (1): 1-7 Nakamura M; Kyo S; Kanaya T; Yatabe N; Maida Y; et al. hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin | 3 | 11 |
| 1048 | 20 | 71 | 5772 2005 CANCER GENE THERAPY 12 (9): 737-748 Uchino J; Takayama K; Harada A; Kawakami Y; Inoue H; et al. Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment | 0 | 3 |
| 1049 | 3 | 37 | 346 1986 CANCER GENETICS AND CYTOGENETICS 21 (1): 67-77 ZECH L; GODAL T; HAMMARSTROM L; MELLSTEDT H; SMITH CIE; et al. SPECIFIC CHROMOSOME MARKERS INVOLVED WITH CHRONIC LYMPHOCYTE-T TUMORS | 1 | 55 |
| 1050 | 4 | 33 | 455 1987 CANCER GENETICS AND CYTOGENETICS 25 (1): 149-159 WALEN KH CHROMOSOME INSTABILITY IN CELL LINEAGES OF AMNIOCYTE CLONES MORPHOLOGICALLY TRANSFORMED BY SIMIAN VIRUS-40 | 2 | 17 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 1051 | 4 | 12 | 456 1987 CANCER GENETICS AND CYTOGENETICS 28 (2): 363-366 KOVACS G; MULLERBRECHLIN R; SZUCS S TELOMERIC ASSOCIATION IN 2 HUMAN RENAL TUMORS | 20 | 62 |
| 1052 | 1 | 75 | 556 1988 CANCER GENETICS AND CYTOGENETICS 34 (1): 125-134 VOLPE JPG GENETIC INSTABILITY OF CANCER - WHY A METASTATIC TUMOR IS UNSTABLE AND A BENIGN-TUMOR IS STABLE | 0 | 54 |
| 1053 | 6 | 43 | 682 1989 CANCER GENETICS AND CYTOGENETICS 39 (2): 203-217 PETKOVIC I; AGBOR P; HITTELMAN WN SIMULTANEOUS CELL TYPE IDENTIFICATION AND PREMATURE CHROMOSOME CONDENSATION ANALYSIS IN A CASE OF MULTIPLE-MYELOMA | 0 | 2 |
| 1054 | 5 | 84 | 940 1991 CANCER GENETICS AND CYTOGENETICS 56 (2): 143-156 KOJIS TL; GATTI RA; SPARKES RS THE CYTOGENETICS OF ATAXIA TELANGIECTASIA | 18 | 82 |
| 1055 | 4 | 34 | 1094 1992 CANCER GENETICS AND CYTOGENETICS 59 (1): 20-25 MEESE EU; HORWITZ SB; TRENT JM EVIDENCE FOR LINEAR EXTRACHROMOSMAL ELEMENTS MEDIATING GENE AMPLIFICATION IN THE MULTIDRUG-RESISTANT J774.2 MURINE CELL-LINE | 0 | 5 |
| 1056 | 7 | 7 | 1095 1992 CANCER GENETICS AND CYTOGENETICS 61 (2): 204-206 ADAMSON DJA; KING DJ; HAITES NE SIGNIFICANT TELOMERE SHORTENING IN CHILDHOOD LEUKEMIA | 54 | 68 |
| 1057 | 10 | 28 | 1270 1993 CANCER GENETICS AND CYTOGENETICS 71 (2): 132-138 SCHWARTZ HS; DAHIR GA; BUTLER MG TELOMERE REDUCTION IN GIANT-CELL TUMOR OF BONE AND WITH AGING | 19 | 37 |
| 1058 | 19 | 29 | 1419 1994 CANCER GENETICS AND CYTOGENETICS 77 (1): 19-25 ROGALLA P; KAZMIERCZAK B; ROHEN C; TRAMS G; BARTNITZKE S; et al. 2 HUMAN BREAST-CANCER CELL-LINES SHOWING DECREASING TELOMERIC REPEAT LENGTH DURING EARLY IN-VITRO PASSAGING | 12 | 18 |
| 1059 | 11 | 15 | 1420 1994 CANCER GENETICS AND CYTOGENETICS 78 (1): 64-67 OHYASHIKI K; OHYASHIKI JH; FUJIMURA T; KAWAKUBO K; SHIMAMOTO T; et al. TELOMERE SHORTENING IN LEUKEMIC-CELLS IS RELATED TO THEIR GENETIC ALTERATIONS BUT NOT REPLICATIVE CAPABILITY | 18 | 22 |
| 1060 | 3 | 224 | 1421 1994 CANCER GENETICS AND CYTOGENETICS 78 (2): 115-126 DONNER LR CYTOGENETICS OF TUMORS OF SOFT-TISSUE AND BONE - IMPLICATION FOR PATHOLOGY | 0 | 13 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 1061 | 19 | 44 | 1616 1995 CANCER GENETICS AND CYTOGENETICS 83 (2): 121-126 TEMPERANI P; GIACOBBI F; GANDINI G; TORELLI U; EMILIA G CHROMOSOME REARRANGEMENTS AT TELOMERIC LEVEL IN HEMATOLOGIC DISORDERS | 1 | 5 |
| 1062 | 10 | 16 | 1854 1996 CANCER GENETICS AND CYTOGENETICS 86 (1): 50-53 Butler MG; Sciadini M; Hedges LK; Schwartz HS Chromosome telomere integrity of human solid neoplasms | 6 | 12 |
| 1063 | 4 | 13 | 1855 1996 CANCER GENETICS AND CYTOGENETICS 89 (1): 31-33 Fugazza G; Bruzzone R; Sessarego M Loss of telomeric sequences in a ring derived from chromosome 8 in refractory anemia with excess of blasts in transformation | 0 | 0 |
| 1064 | 15 | 46 | 1856 1996 CANCER GENETICS AND CYTOGENETICS 90 (2): 157-165 Gagos S; Iliopoulos D; TseleniBalafouta S; Agapitos M; Antachopoulos C; et al. Cell senescence and a mechanism of clonal evolution leading to continuous cell proliferation, loss of heterozygosity, and tumor heterogeneity: Studies on two immortal colon cancer cell lines | 1 | 7 |
| 1065 | 28 | 41 | 2163 1997 CANCER GENETICS AND CYTOGENETICS 94 (1): 67-72 Ohyashiki K; Ohyashiki JH Telomere dynamics and cytogenetic changes in human hematologic neoplasias: A working hypothesis | 3 | 8 |
| 1066 | 7 | 27 | 2164 1997 CANCER GENETICS AND CYTOGENETICS 95 (2): 166-172 Wan TSK; Chan LC; Ngan HYS; Tsao SW High frequency of telomeric associations in human ovarian surface epithelial cells transformed by human papilloma viral oncogenes | 6 | 20 |
| 1067 | 13 | 35 | 2165 1997 CANCER GENETICS AND CYTOGENETICS 98 (2): 115-118 PazyMino C; Sanchez ME; DelPozo M; Baldeon MA; Cordova A; et al. Telomeric association in women with breast and uterine cervix cancer | 1 | 3 |
| 1068 | 13 | 17 | 2525 1998 CANCER GENETICS AND CYTOGENETICS 105 (2): 138-144 Butler MG; Tilburt J; DeVries A; Muralidhar B; Aue G; et al. Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages | 5 | 14 |
| 1069 | 6 | 28 | 3368 2000 CANCER GENETICS AND CYTOGENETICS 118 (2): 112-120 Hu YC; Lam KY; Wan TSK; Fang WG; Ma ESK; et al. Establishment and characterization of HKESC-1, a new cancer cell line from human esophageal squamous cell carcinoma | 0 | 13 |
| 1070 | 7 | 33 | 4730 2003 CANCER GENETICS AND CYTOGENETICS 145 (1): 38-48 Sawyer JR; Husain M; Lukacs JL; Stangeby C; Binz RL; et al. Telomeric fusion as a mechanism for the loss of 1p in meningioma | 0 | 4 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 1071 | 8 | 37 | 5773 2005 CANCER GENETICS AND CYTOGENETICS 163 (1): 12-16 Amiel A; Goldzak G; Gaber E; Yosef G; Fejgin MD; et al. Random aneuploidy and telomere capture in chronic lymphocytic leukemia and chronic myeloid leukemia patients | 1 | 3 |
| 1072 | 5 | 109 | 6291 2006 CANCER IMMUNOLOGY IMMUNOTHERAPY 55 (1): 85-95 Baxevanis CN; Sotiriadou NN; Gritzapis AD; Sotiropoulou PA; Perez SA; et al. Immunogenic HER-2/neu peptides as tumor vaccines | 0 | 1 |
| 1073 | 43 | 51 | 2526 1998 CANCER INVESTIGATION 16 (3): 170-174 Rowley PT Telomerase: Putting an end to DNA | 3 | 5 |
| 1074 | 53 | 77 | 3369 2000 CANCER INVESTIGATION 18 (3): 269-277 Davis AJ; Siu LL Telomerase: Therapeutic potential in cancer | 2 | 6 |
| 1075 | 6 | 117 | 4236 2002 CANCER INVESTIGATION 20 (1): 71-81 Munger K Disruption of oncogene/tumor suppressor networks during human carcinogenesis | 0 | 16 |
| 1076 | 85 | 135 | 4237 2002 CANCER INVESTIGATION 20 (1): 82-101 Helder MN; Wisman GBA; van der Zee AGJ Telomerase and telomeres: From basic biology to cancer treatment | 11 | 20 |
| 1077 | 85 | 128 | 2527 1998 CANCER JOURNAL 4: S26-S34 Shay JW Telomerase in cancer: Diagnostic, prognostic, and therapeutic implications | 16 | 25 |
| 1078 | 15 | 133 | 5774 2005 CANCER JOURNAL 11 (4): 294-305 Wang LL Biology of osteogenic sarcoma | 0 | 0 |
| 1079 | 7 | 10 | 2528 1998 CANCER JOURNAL FROM SCIENTIFIC AMERICAN 4: S22-S25 de Lange T Length control of human telomeres | 9 | 12 |
| 1080 | 18 | 26 | 1857 1996 CANCER LETTERS 106 (2): 155-161 Rogalla P; Rohen C; Bonk U; Bullerdiek J Telomeric repeat fragment lengths are not correlated to histological grading in 85 breast cancers | 6 | 9 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 1081 | 8 | 20 | 2166 1997 CANCER LETTERS 117 (1): 67-71 Kido A; Tsujiuchi T; Tsutsumi M; Takahama M; Miyauchi Y; et al. Increased telomerase activity is not directly related to metastatic potential in rat transplantable osteosarcomas | 4 | 9 |
| 1082 | 21 | 32 | 2529 1998 CANCER LETTERS 122 (1-2): 115-120 Tsujiuchi T; Tsutsumi M; Kido A; Takahama M; Sakitani H; et al. Induction of telomerase activity during regeneration after partial hepatectomy in the rat | 9 | 15 |
| 1083 | 20 | 50 | 2530 1998 CANCER LETTERS 126 (2): 157-164 Sakitani H; Tsujiuchi T; Kobitsu K; Kido A; Iki K; et al. Increased telomerase activity and absence of p53 mutation in oligoastrocytomas induced by N-ethyl-N-nitrosourea in rats | 1 | 3 |
| 1084 | 26 | 45 | 2531 1998 CANCER LETTERS 131 (2): 185-190 Iki K; Tsujiuchi T; Majima T; Sakitani H; Tsutsumi M; et al. Increased telomerase activity in intrahepatic cholangiocellular carcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters | 1 | 2 |
| 1085 | 9 | 21 | 2960 1999 CANCER LETTERS 141 (1-2): 187-194 Ishikawa T; Kamiyama M; Hisatomi H; Ichikawa Y; Momiyama N; et al. Telomerase enzyme activity and RNA expression in Adriamycin-resistant human breast carcinoma MCF-7 cells | 6 | 13 |
| 1086 | 20 | 34 | 2961 1999 CANCER LETTERS 142 (1): 23-30 Akiyama M; Iwase S; Horiguchi-Yamada J; Saito S; Furukawa Y; et al. Interferon-alpha repressed telomerase along with G1-accumulation of Daudi cells | 4 | 8 |
| 1087 | 13 | 52 | 3370 2000 CANCER LETTERS 152 (1): 53-61 Chou MW; Mikhailova MV; Nichols J; Poirier LA; Warbritton A; et al. Interactive effects of methyl-deficiency and dietary restrictionon liver cell proliferation and telomerase activity in Fischer 344 rats pretreated with aflatoxin B-1 | 0 | 3 |
| 1088 | 17 | 23 | 3371 2000 CANCER LETTERS 158 (2): 179-184 Nakamura K; Furugori E; Esaki Y; Arai T; Sawabe M; et al. Correlation of telomere lengths in normal and cancers tissue in the large bowel | 8 | 14 |
| 1089 | 23 | 34 | 3372 2000 CANCER LETTERS 159 (2): 141-149 Gollahon LS; Holt SE Alternative methods of extracting telomerase activity from human tumor samples | 2 | 9 |
| 1090 | 24 | 42 | 3373 2000 CANCER LETTERS 159 (2): 175-181 Kammori M; Takubo K; Nakamura KI; Furugouri E; Endo H; et al. Telomerase activity and telomere length in benign and malignant human thyroid tissues | 10 | 20 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 1091 | 17 | 28 | 3792 2001 CANCER LETTERS 168 (1): 45-50 Sagawa Y; Nishi H; Isaka K; Fujito A; Takayama M The correlation of TERT expression with c-myc expression in cervical cancer | 8 | 15 |
| 1092 | 27 | 43 | 3793 2001 CANCER LETTERS 168 (2): 111-116 von Zglinicki T Telomeres and replicative senescence: is it only length that counts? | 14 | 22 |
| 1093 | 16 | 29 | 4238 2002 CANCER LETTERS 178 (2): 187-197 Akiyama M; Yamada O; Kanda N; Akita S; Kawano T; et al. Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors | 12 | 25 |
| 1094 | 19 | 43 | 4239 2002 CANCER LETTERS 187 (1-2): 191-198 Fukushima T; Yoshino A; Katayama Y; Watanabe T; Kusama K; et al. Prediction of clinical course of diffusely infiltrating astrocytomas from telomerase expression and quantitated activity level | 2 | 3 |
| 1095 | 5 | 11 | 4731 2003 CANCER LETTERS 194 (2): 137-138 von Zglinicki T Telomeres, telomerase and the cancer cell: an introduction | 0 | 1 |
| 1096 | 194 | 235 | 4732 2003 CANCER LETTERS 194 (2): 139-154 Harrington L Biochemical aspects of telomerase function | 39 | 41 |
| 1097 | 45 | 52 | 4733 2003 CANCER LETTERS 194 (2): 155-162 Reddel RR Alternative lengthening of telomeres, telomerase, and cancer | 46 | 56 |
| 1098 | 72 | 111 | 4734 2003 CANCER LETTERS 194 (2): 163-172 Masutomi K; Hahn WC Telomerase and tumorigenesis | 8 | 16 |
| 1099 | 55 | 104 | 4735 2003 CANCER LETTERS 194 (2): 173-182 Desmaze C; Soria JC; Freulet-Marriere MA; Mathieu N; Sabatier L Telomere-driven genomic instability in cancer cells | 8 | 16 |
| 1100 | 37 | 47 | 4736 2003 CANCER LETTERS 194 (2): 183-188 Blasco MA Telomeres in cancer and aging: lessons from the mouse | 7 | 13 |
Page 11 of 66: 1 [ 11 12 13 14 15 16 17 18 19 20 ] 21 31 41 51 61
Generated by HistCite 2006.08.14